Top Markets
Coin of the day
Omnimmune Holdings, Inc. Omnimmune Holdings, Inc.

Omnimmune Holdings, Inc.

OMMH
Kedudukan dalam Saham #42527
Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as... Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic, and prognostic technologies in the United States. The company owns rights for monoclonal antibody technologies. It also intends to develop personalized cancer treatment with the selection of prophylactic and therapeutic vaccines (active immunization), monoclonal antibodies (passive immunization), and genomic-based products, which target a hormone called human chorionic gonadotropin. In addition, the company plans to conduct a Phase I trial with its lead candidate anti-human chorionic gonadotropin beta subunit monoclonal antibodies based upon the results of the diagnostic trial. Omnimmune Holdings, Inc. is based in Houston, Texas.
Harga Saham
$0.0001
Disegerakkan terakhir: 2026-07-17
Modal Pasaran
$981.00
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Omnimmune Holdings, Inc. (OMMH)

Kategori

Sejarah hasil dividen untuk Omnimmune Holdings, Inc. (OMMH)
Hasil dividen (TTM) bagi Omnimmune Holdings, Inc. (simbol saham: OMMH) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Omnimmune Holdings, Inc. (OMMH) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing